Latest filing published 13 Jul 2026 for 엔솔바이오사이언스.
Insider track record
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
형인우: trading record in brief
형인우 is a declared insider of 엔솔바이오사이언스, with filings sourced from DART (FSS). We count 15 filings; the first trade dates from 10 March 2021 and the latest from 13 July 2026.
Purchases make up the whole of the open-market record (14 purchases). The totals do not cover 14 filings with an undisclosed amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2026 alone, the filings show 1 purchase and no sales.
Across 10 purchases, this insider has always bought alone, with no colleague buying within 30 days.
The latest filing, published on 13 July 2026, reports an open-market purchase in 엔솔바이오사이언스. The median gap between a trade and its publication by DART (FSS) is 3 days. Until a filing is published, the market cannot know about the trade. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to 형인우
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 550,055 sharesKRXDART:20230710000133Canonical exit: 3 Sept 2023 (T+90)
- 550,055 sharesKRXDART:20221209000613Canonical exit: 9 Mar 2023 (T+90)
- 550,055 sharesKRXDART:20210810000213Canonical exit: 8 Nov 2021 (T+90)
- 550,055 sharesKRXDART:20210614000273Canonical exit: 12 Sept 2021 (T+90)
- 550,055 sharesKRXDART:20210409002209Canonical exit: 8 Jul 2021 (T+90)
- 550,055 sharesKRXDART:20210310000571Canonical exit: 8 Jun 2021 (T+90)
15 of 15 declarations